Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane and Tamoxifen in Locally Advanced Breast Cancer
NCT00919399Phase 2Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Jan 2002
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane, tamoxifen in breast cancer, sponsored by Institut Claudius Regaud. Started Jan 2002; status: completed.
02
Drugs
exemestanetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00919399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919399.